{"name":"PRCL Research Inc.","slug":"prcl-research-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPLVBJeFZJZml5ekJDN2c5WVZScTlYV0hlelcwdzQxMlhVMkoxcTd1aVRYUzA0cXpRbHptXzd3QVl1UWxDYUVNVmZtR203azJwOF9wNE43YlFyc3F2RjhDZ1l2dlJzZzJrWWRCM0M1a1pYSTdxUTkwdDJfcUNFRERYS1FBMzZRNlEtZGZLU3ozTk1PV25jSGNJ?oc=5","date":"2026-03-11","type":"pipeline","source":"openPR.com","summary":"Peripheral T-Cell Lymphoma Market Outlook 2034: US Market - openPR.com","headline":"Peripheral T-Cell Lymphoma Market Outlook 2034: US Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1PZ2pKci1UZ181b09DNXo2N2RBc3B2RjV2TThaMDg2X0FIaXFTd2J5UTRPQXBZZGlEbHdTbXppQWo0ZzdjYzA3ZFZkdVpSNnU2TWJtcEVKcS1CN1RkMVZSclAwYlotVEJqcDhsejRHWHRPbUo5LVBLcEhTYw?oc=5","date":"2023-11-30","type":"pipeline","source":"ScienceDirect.com","summary":"Orai1 Ca2+ channel modulators as therapeutic tools for treating cancer: Emerging evidence! - ScienceDirect.com","headline":"Orai1 Ca2+ channel modulators as therapeutic tools for treating cancer: Emerging evidence!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNNXdGLXRKSVJ0UFRRR2V3RHBxTjRGalRXbldEand1UEdoTEQyMHlDeEtMUzlHZGhqOXZPX3REel84WkJVMEIzQTRld1JwQXZiaHJKT0pNdTlKRWJSRjlfWVJaZ0FFcVp2azQ5U3pOdWNRek1US05YTHFXWTdBZ0J6Y0hCOXlaZEM3SHFEWg?oc=5","date":"2018-04-18","type":"pipeline","source":"Eli Lilly","summary":"Lilly.ca | Lilly Canada - Eli Lilly","headline":"Lilly.ca | Lilly Canada","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}